#$%$ of the Decade. Pay attention. As previously stated here, the targeted tumor size is 3 to 7cm. This trial has been designed for success. Fast Track, Orphan Status, Patent Protection...The FDA WANTS this platform.
A cancer patient with 6 months to live would do anything for another two or three months, let alone another six to a year. It's a done deal; you should have covered.
But this study is on intermediate HCC and large tumors between 3 and 7 cm--not small tumors. These have shown a documented median recurrence time of 12 months in almost every study using just RFA. The bar for Thermodox plus RFA is not that high---and the higher it goes so does the stock price.
Idiot Shorts: Does not matter if data is bad. Trading has been halted. Makes no difference to price. If good data open higher, if bad data open at 1 ish. You are like a little fly that just won't go away. Get a life cause it is short and precious.People with cancer sure wish they have more time. Therefore I hope Thermo works. Out